← FDA Drug Approvals (Drugs@FDA)
OXALIPLATIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2010-06-02
Drug application
- FDA Application #
ANDA078819- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OXALIPLATIN
- Generic name
- Oxaliplatin
- Active ingredients
- OXALIPLATIN
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- FRESENIUS KABI USA
- First approval
- 2010-06-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown